CareMax Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Revenue	751.1	631.13	295.76	103.42	90.6
Revenue Growth (YoY)	19.01%	113.39%	185.98%	14.15%	-
Cost of Revenue	737.2	550.83	264.31	83.42	51.62
Gross Profit	13.9	80.3	31.45	20	38.98
Selling, General & Admin	94.96	87.59	45.53	8.82	32.41
Other Operating Expenses	575.1	104.88	14.74	1.5	0
Operating Expenses	670.05	192.47	60.27	10.32	32.41
Operating Income	-656.15	-112.17	-28.82	9.68	6.57
Interest Expense / Income	54.43	20.46	4.49	1.66	0.72
Other Expense / Income	-26.38	-75.28	-26.8	0.42	-0.17
Pretax Income	-684.21	-57.34	-6.52	7.6	6.02
Income Tax	-0.86	-19.54	0.16	0	0
Net Income	-683.35	-37.8	-6.68	7.6	6.02
Net Income Growth	-	-	-	26.29%	-
Shares Outstanding (Basic)	4	3	2	0	-
Shares Outstanding (Diluted)	4	3	2	0	-
Shares Change	23.16%	72.55%	387.41%	-	-
EPS (Basic)	-183.31	-12.49	-3.90	21.00	-
EPS (Diluted)	-183.31	-12.49	-3.90	21.00	-
Free Cash Flow	-61.52	-75.67	-27.85	2.84	6.28
Free Cash Flow Per Share	-16.50	-25.00	-15.88	7.88	-
Gross Margin	1.85%	12.72%	10.63%	19.34%	43.02%
Operating Margin	-87.36%	-17.77%	-9.75%	9.36%	7.25%
Profit Margin	-90.98%	-5.99%	-2.26%	7.35%	6.64%
Free Cash Flow Margin	-8.19%	-11.99%	-9.42%	2.74%	6.94%
EBITDA	-590.04	-15.16	11.19	10.76	7.71
EBITDA Margin	-78.56%	-2.40%	3.78%	10.41%	8.52%
Depreciation & Amortization	39.73	21.72	13.22	1.5	0.98
EBIT	-629.78	-36.88	-2.02	9.26	6.74
EBIT Margin	-83.85%	-5.84%	-0.68%	8.95%	7.44%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).